{"commentary":{"count":16,"free_build_floor":8,"listing_floor":3,"by_channel":{"youtube":10,"podcast":3,"x_thread":3},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT03616587\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"SERENA-1","nct_id":"NCT03616587","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=serena-1-nct03616587. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 13–40 commentary sources"},"registry":{"acronym":"SERENA-1","arms":[{"description":null,"label":"AZD9833 monotherapy dose escalation","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 monotherapy dose expansion","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with palbociclib dose escalation","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with palbociclib dose expansion","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with everolimus dose expansion","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with everolimus dose escalation","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with abemaciclib (± anastrozole) dose escalation","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with abemaciclib (± anastrozole)dose expansion","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with capivasertib dose escalation","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with capivasertib dose expansion","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with ribociclib (± anastrozole) dose escalation","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with ribociclib (± anastrozole) dose expansion","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with anastrozole dose escalation","type":"EXPERIMENTAL"},{"description":null,"label":"AZD9833 with anastrozole dose expansion","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2027-06-24","type":"ESTIMATED"},"conditions":["ER+ HER2- Advanced Breast Cancer"],"enrollment":{"count":396,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"AZD9833","type":"DRUG"},{"name":"AZD9833","type":"DRUG"},{"name":"AZD9833 with palbociclib","type":"DRUG"},{"name":"AZD9833 with palbociclib","type":"DRUG"},{"name":"AZD9833 with everolimus","type":"DRUG"},{"name":"AZD9833 with everolimus","type":"DRUG"},{"name":"AZD9833 with abemaciclib","type":"DRUG"},{"name":"AZD9833 with abemaciclib","type":"DRUG"},{"name":"AZD9833 with capivasertib","type":"DRUG"},{"name":"AZD9833 with capivasertib","type":"DRUG"},{"name":"AZD9833 with ribociclib","type":"DRUG"},{"name":"AZD9833 with ribociclib","type":"DRUG"},{"name":"AZD9833 with anastrozole","type":"DRUG"},{"name":"AZD9833 with anastrozole","type":"DRUG"}],"last_update":"2026-08-18","lead_sponsor":"AstraZeneca","official_title":"A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women With ER-positive, HER2-negative Advanced Breast Cancer (SERENA-1)","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE1"],"primary_completion_date":{"date":"2024-09-16","type":"ACTUAL"},"primary_outcomes":[{"measure":"The number of subjects with dose-limiting toxicity, as defined in the protocol.","timeFrame":"Minimum observation period 28 days on treatment."},{"measure":"The number of subjects with treatment-related adverse events as assessed by CTCAE v4.03.","timeFrame":"Minimum observation period 28 days on treatment, and will continue until the subject is off the study (approximately 1 year)."}],"references":[],"start_date":{"date":"2018-10-11","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.","url":"https://clinicaltrials.gov/study/NCT03616587"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/serena-1-nct03616587"}